FR
Search all our fact sheets and resources
Healthy pregnancy hub

Nitrofurantoin (Macrolid®)

Last Update: 22 May 2025

Welcome to our fact sheet on nitrofurantoin during pregnancy and breastfeeding/chestfeeding. This information is based on available published literature. It should not take the place of medical care and advice from your healthcare provider.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic. The original version is available here (February 2024).

Serene, our chatbot, can also answer your questions about medications during pregnancy.

Please note that this fact sheet is based on United States information and has been adapted for Canada, with a review by our Canadian experts. Minor differences may exist between the two countries. Always consult your healthcare professional for information tailored to your situation.

1. What is nitrofurantoin?

Nitrofurantoin is an antibacterial medication that has been used to treat urinary tract infections (UTIs). Some brand names are Macrobid®, Macrodantin®, and Furadantin®. 

Sometimes when people find out they are pregnant, they think about changing how they take their medication, or stopping their medication altogether. However, it is important to talk with your healthcare providers before making any changes to how you take your medication. Your healthcare provider can talk with you about using nitrofurantoin and what treatment is best for you. 

The American College of Obstetricians and Gynecologists (ACOG) states that it is “reasonable to offer” nitrofurantoin in the first trimester when other medication is not available. ACOG also states that the use of nitrofurantoin in the second and third trimester has been considered a first-line treatment for UTIs. 

The product label for nitrofurantoin recommends that individuals who are near the end of their pregnancy (38 to 42 weeks gestation) or are otherwise close to delivery should not use this medication. 

 

2. What does research say about the risks during pregnancy?

I take nitrofurantoin. Can it make it harder for me to get pregnant?

It is not known if nitrofurantoin can make it harder to get pregnant.

Does taking nitrofurantoin increase the chance of miscarriage?

Miscarriage is common and can occur in any pregnancy for many different reasons. Two studies including 173 pregnancies did not find an association with nitrofurantoin use and an increased chance for miscarriage. However, pregnant individuals with untreated urine infections might have a greater chance for miscarriage. 

Does taking nitrofurantoin increase the chance of birth defects? 

Every pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. Most studies with nitrofurantoin do not suggest an increased chance of birth defects. Some studies on nitrofurantoin have suggested an increased chance of birth defects with use in pregnancy. However, study design flaws make some of the results in these studies questionable. There are also many studies on nitrofurantoin use in pregnancy that did not find birth defects. Overall, an increased chance for birth defects has not been confirmed. 

Does taking nitrofurantoin in pregnancy increase the chance of other pregnancy-related problems?

It is not known if nitrofurantoin can cause other pregnancy-related problems, such as preterm delivery (birth before week 37) or low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth). However, pregnant individuals with untreated urine infections might have a greater chance for these and other pregnancy complications, including preeclampsia (high blood pressure and problems with organs, such as the kidneys) that can lead to seizures (called eclampsia), and cesarean section (C-section). 

There have been reports of newborns with hemolytic anemia (breakdown of red blood cells) when they were exposed to nitrofurantoin late in pregnancy. For this reason, the manufacturer has recommended using different antibiotics to treat urine infections later in pregnancy. 

Does taking nitrofurantoin in pregnancy affect future behavior or learning for the child?

Studies have not been done to see if nitrofurantoin can cause behavior or learning issues for the child. 

3. Breastfeeding​/ chestfeeding​ while taking nitrofurantoin

Nitrofurantoin gets into breast milk in small amounts. In a report on 6 individuals taking nitrofurantoin while breastfeeding or chestfeeding, 2 noted that their children had diarrhea. When any antibiotic is taken during breastfeeding or chestfeeding, babies can be watched for diarrhea or rash. 

The product label for nitrofurantoin recommends that people who are breastfeeding or chestfeeding should not use this medication when infants are less than 1 month old or if the nursing infant has a diagnosis of glucose-6-phosphate dehydrogenase deficiency (G6PD) due to the risk of hemolytic anemia (breakdown of red blood cells). However, the benefits of treating your condition, as well as the benefits of breastfeeding or chestfeeding, may outweigh possible risks. Use of nitrofurantoin while breastfeeding or chestfeeding an older infant without G6PD is unlikely to cause side effects. Your healthcare providers can talk with you about using nitrofurantoin and what treatment is best for you while you are nursing. Be sure to talk to your healthcare provider about all your breastfeedin or chestfeeding questions. 

4. What about fathers and sperm donors?

If a male takes nitrofurantoin, could it affect fertility or increase the chance of birth defects?

When nitrofurantoin was given to male at doses higher than typically used for 2 weeks, sperm production was low or stopped in 13 out of the 36 study participants. Low sperm production could affect fertility (ability to get a partner pregnant). However, use of typical doses of 100mg twice daily for one week did not have this same effect. This means that with typical use, nitrofurantoin is unlikely to affect a male’s fertility. In general, exposures that fathers or sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures here.

Key points

  • Nitrofurantoin (Macrobid®, Macrodantin®, Furadantin®) is an antibiotic prescribed to treat urinary tract infections.
  • Most studies have not found a link between this medication and an increased risk of miscarriage or birth defects. It is unknown whether it may increase the risk of other pregnancy complications.
  • Nitrofurantoin can be used during pregnancy, but the manufacturer advises against using it late in pregnancy (between 38 and 42 weeks) due to a rare risk of anemia in the newborn.
  • Nitrofurantoin passes into breast milk in small amounts. It is generally considered safe while breastfeeding, unless the baby is under one month old or has a rare condition called G6PD deficiency.
  • Always talk to your healthcare provider to discuss the benefits and risks of this treatment during pregnancy or breastfeeding.

References

Please click here to view references.

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Anne-Sophie Otis
Centre Hospitalier Sainte-Justine
Émy Roberge
Centre hospitalier universitaire Sainte-Justine

Associated Fact Sheets

You want to know more about this topis? Discover our associated Fact Sheets!

Associated Resources

Want to know more? Discover our other contents associated to the topic.

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Saskatchewan
University of Manitoba
University of Alberta
Unité de soutien SSA
UDEM
Stratos
SOGC
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Alberta Health Services
MICYRN
UQAT
Dalhousie University